Synthetic thrombus model for learning the surgical removal of a blood clot in the context of a treatment simulation
Synthetic thrombus model for learning the surgical removal of a blood clot from a blood vessel using mechanical thrombectomy in a simulation of various stroke scenarios in a training model, which simulates a lifelike shape with a realistic feel of a human blood clot thereby that an elongated base body based on an elastically deformable main material with a Shore A hardness in the range of 0 to 10 is provided, the property profile of which at least with respect to hardness and fragmentation is improved by providing a material combination of the main material with at least one addition of an adhesive with 5 to 40 wt.-% and/or with a reinforcing material.
1 . A synthetic thrombus model for learning a surgical removal of a blood clot from a blood vessel using mechanical thrombectomy in a simulation of various stroke scenarios in a training model, the synthetic thrombus model comprising:
an elongated base body formed from an elastically deformable main material having a Shore A hardness in a range of 0 to 10, wherein the elastically deformable main material comprises agarose or silicone rubber; and
an adhesive present in an amount of 5 to 40% by weight, wherein the adhesive comprises chloromethylisothiazolinone (CMIT), a mixture of CMIT and methylisothiazolinone (MIT), or both, and wherein the adhesive is combined with the elastically deformable main material to improve at least the hardness and fragmentation properties of the synthetic thrombus model.
2 . The synthetic thrombus model of claim 1 , wherein the elastically deformable main material is formed by a gelled agarose base.
3 . The synthetic thrombus model of claim 2 , wherein the gelled agarose base is prepared with a concentration of 2% to 5%.
4 . The synthetic thrombus model of claim 1 , wherein the elastically deformable main material is agarose, present in a concentration of 2% to 3%, and the adhesive is a mixture of CMIT and MIT present in an amount of 5% to 20% by weight.
5 . The synthetic thrombus model of claim 1 , wherein the elastically deformable main material is silicone rubber, comprising a silicone base portion having Shore A hardness 0 in an amount of 30% to 35% by weight, and an adhesive comprising CMIT and/or MIT present in an amount of 30% to 40% by weight.
6 . The synthetic thrombus model of claim 1 , wherein the synthetic thrombus model further comprises a reinforcing material forming a support structure within the elongated base body.
7 . The synthetic thrombus model of claim 6 , wherein the support structure is formed as a spiral structure, wave structure, or spike-like structure, a respective longitudinal extension of which follows a longitudinal extension of the elongated base body.
8 . The synthetic thrombus model of claim 6 , wherein the support structure comprises micro glass beads.
9 . The synthetic thrombus model of claim 6 , wherein the support structure is present in an amount of 10% to 40% by weight.
10 . The synthetic thrombus model of claim 1 , wherein the elongated base body has reduced surface adhesion behavior due to temporary storage in a vegetable edible oil.
11 . The synthetic thrombus model of claim 1 , wherein the elongated base body is shaped by a casting process or an injection molding process.
12 . A synthetic thrombus model for learning a surgical removal of a blood clot from a blood vessel using mechanical thrombectomy in a simulation of various stroke scenarios in a training model, the synthetic thrombus model comprising:
an elongated base body formed from an elastically deformable main material having a Shore A hardness in a range of 0 to 10, wherein the elastically deformable main material comprises agarose or silicone rubber; and
a reinforcing material forming a support structure within the elongated base body, wherein the support structure is formed as a spiral structure, wave structure or spike-like structure, a respective longitudinal extension of which follows a longitudinal extension of the elongated base body.
13 . The synthetic thrombus model of claim 12 , wherein the elastically deformable main material is formed by a gelled agarose base.
14 . The synthetic thrombus model of claim 13 , wherein the gelled agarose base is prepared with a concentration of 2% to 5%.
15 . The synthetic thrombus model of claim 12 , further comprising an adhesive present in an amount of 5% to 40% by weight, wherein the adhesive comprises chloromethylisothiazolinone (CMIT), a mixture of CMIT and methylisothiazolinone (MIT), or both.
16 . The synthetic thrombus model of claim 15 , wherein the adhesive is a mixture of CMIT and MIT present in an amount of 5% to 20% by weight.
17 . The synthetic thrombus model of claim 15 , wherein the support structure comprises micro glass beads.
18 . The synthetic thrombus model of claim 17 , wherein the support structure is present in an amount of 10% to 40% by weight.
19 . The synthetic thrombus model of claim 12 , wherein the elongated base body has reduced surface adhesion behavior due to temporary storage in a vegetable edible oil.
20 . The synthetic thrombus model of claim 12 , wherein the elongated base body is shaped by a casting process or an injection molding process.